Research Grants 16,040 show all


$157M
2015

$175.5M
2016

$188.1M
2017

$183.4M
2018

$65M
2019

Patents 3,250show all

  • 1,531
    A61K - Preparations for medical, dental, or toilet purposes
  • 837
    C07K - Peptides
  • 616
    G01N - Investigating or analysing materials by determining their chemical or physical properties
  • 594
    C12N - Microorganisms or enzymes
  • 256
    Y02A - Technologies for adaptation to climate change
  • 226
    C12Q - Measuring or testing processes involving enzymes, nucleic acids or microorganisms
  • 213
    A61B - Diagnosis
  • 152
    C07D - Heterocyclic compounds
  • 145
    C07C - Acyclic or carbocyclic compounds
  • 131
    A61P - Specific therapeutic activity of chemical compounds or medicinal preparations

Publications 2,026 show all

  • 33
    Antineoplastic Combined Chemotherapy Protocols/therapeutic use
  • 30
    Lung Neoplasms/drug therapy
  • 25
    Carcinoma, Non-Small-Cell Lung/drug therapy
  • 21
    Antineoplastic Agents/pharmacology
  • 16
    Leukemia, Myeloid, Acute/drug therapy
  • 13
    Antineoplastic Agents/therapeutic use
  • 13
    Drug Approval
  • 12
    Attitude of Health Personnel
  • 12
    Breast Neoplasms/drug therapy
  • 12
    Calcium/metabolism

Clinical Trials 539show all

169Phase 3160Phase 253N/A47Phase 127Phase 1/Phase 232Other

Contact Information

Baltimore, MD
United States